carmustine has been researched along with Meningitis in 5 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Meningitis: Inflammation of the coverings of the brain and/or spinal cord, which consist of the PIA MATER; ARACHNOID; and DURA MATER. Infections (viral, bacterial, and fungal) are the most common causes of this condition, but subarachnoid hemorrhage (HEMORRHAGES, SUBARACHNOID), chemical irritation (chemical MENINGITIS), granulomatous conditions, neoplastic conditions (CARCINOMATOUS MENINGITIS), and other inflammatory conditions may produce this syndrome. (From Joynt, Clinical Neurology, 1994, Ch24, p6)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although carmustine (Gliadel) wafers improve local tumor control and extend the overall survival in patients with malignant glioma, adverse effects have been documented." | 3.85 | Eosinophilic meningitis triggered by implanted Gliadel wafers: case report. ( Ivanova, A; Saito, K; Sato, Y; Takeishi, G; Takeshima, H; Yamasaki, K; Yokogami, K, 2017) |
| "Here, we report a case of external hydrocephalus caused by Gliadel-induced eosinophilic meningitis that has been previously reported in only 1 case and can be diagnosed by time-spatial labeling inversion pulse magnetic resonance imaging (time-SLIP MRI)." | 1.48 | Novel Application of Time-Spatial Labeling Inversion Pulse Magnetic Resonance Imaging for Diagnosis of External Hydrocephalus. ( Abe, M; Adachi, K; Hirose, Y; Kumai, T; Murayama, K; Nakae, S, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakae, S | 1 |
| Murayama, K | 1 |
| Adachi, K | 1 |
| Kumai, T | 1 |
| Abe, M | 1 |
| Hirose, Y | 1 |
| Saito, K | 1 |
| Yamasaki, K | 1 |
| Yokogami, K | 1 |
| Ivanova, A | 1 |
| Takeishi, G | 1 |
| Sato, Y | 1 |
| Takeshima, H | 1 |
| Estivill, X | 1 |
| Puig, J | 1 |
| Brunet, S | 1 |
| Domingo-Albós, A | 1 |
| Haghbin, M | 2 |
| Tan, CC | 1 |
| Clarkson, BD | 2 |
| Miké, V | 1 |
| Burchenal, JH | 2 |
| Murphy, ML | 1 |
| Dowling, MD | 1 |
| Gee, TS | 1 |
| Cunningham, B | 1 |
| Tan, CT | 1 |
5 other studies available for carmustine and Meningitis
| Article | Year |
|---|---|
Novel Application of Time-Spatial Labeling Inversion Pulse Magnetic Resonance Imaging for Diagnosis of External Hydrocephalus.
Topics: Aged, 80 and over; Antineoplastic Agents; Brain Neoplasms; Carmustine; Decanoic Acids; Glioma; Human | 2018 |
Eosinophilic meningitis triggered by implanted Gliadel wafers: case report.
Topics: Antineoplastic Agents; Brain; Brain Neoplasms; Carmustine; Decanoic Acids; Drug Delivery Systems; Dr | 2017 |
[High-doses BCNU in diseases of the central nervous system caused by myeloma].
Topics: Carmustine; Humans; Meningitis; Multiple Myeloma; Spinal Cord Compression | 1985 |
Intensive chemotherapy in children with acute lymphoblastic leukemia (L-2 protocol).
Topics: Administration, Oral; Adolescent; Age Factors; Antineoplastic Agents; Asparaginase; Carmustine; Chem | 1974 |
Comparative results obtained in the treatment of acute leukemia.
Topics: Antineoplastic Agents; Asparaginase; Carmustine; Cytarabine; Daunorubicin; Drug Therapy, Combination | 1973 |